Citi downgrades Sumitomo Dainippon Pharma to 'sell' with a price target of JPY400.00 QA

  • Investing.com
Citi downgrades Sumitomo Dainippon Pharma to 'sell' with a price target of JPY400.00 QA

An analyst from Citi downgraded Sumitomo Dainippon Pharma (TYO: 4506 ) from 'neutral' to 'sell' with a price target of JPY400.00 from a prior price target of %currency%%price%.

Prior to this rating, Sumitomo Dainippon Pharma had 0 buy ratings, 4 hold ratings, and 4 sell ratings.

For consensus analyst estimates and price targets on Sumitomo Dainippon Pharma, click here. For more news on Sumitomo Dainippon Pharma, click here.

Sumitomo Dainippon Pharma's stock price closed at $668.0. They are up 3.04% in the last month and down -55.7% in the last 12 months.

According to Investing Pro, Sumitomo Dainippon Pharma's fair value is $600.6, a downside of -22.4%. Sumitomo Dainippon Pharma's fair value comes with a high degree of uncertainty, according to InvestingPro.

Check out Sumitomo Dainippon Pharma's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles